Alterations in long noncoding RNAs in women with and without polycystic ovarian syndrome

Long noncoding RNAs (lncRNAs) are RNA transcripts over 200 nucleotides long that are not translated into protein; however, there is increasing evidence of their regulatory functions. To date, there are few studies measuring lncRNA in control women or women with polycystic ovary syndrome (PCOS).

• Publication year

  2019

• Venue

  Clinical Endocrinology

• Publication date

  2019-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/cen.14087PMID 31482638
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long Non-Coding RNAs in the Regulation of Gene Expression: Physiology and Disease

  2019cited by this paper
• Long Noncoding RNAs: Potential Regulators Involved in the Pathogenesis of Polycystic Ovary Syndrome

  2017cited by this paper
• LncRNAs: key players and novel insights into diabetes mellitus

  2017cited by this paper
• Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability

  2016cited by this paper
• Genome-Wide Identification of Long Noncoding RNAs in Rat Models of Cardiovascular and Renal Disease

  2015cited by this paper
• Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

  2014cited by this paper
• Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• MicroRNAs Related to Polycystic Ovary Syndrome (PCOS)

  2014cited by this paper
• The long non-coding RNAs : a new ( p ) layer in the “ dark matter ”

  2014cited by this paper
• Pervasive Transcription of the Human Genome Produces Thousands of Previously Unidentified Long Intergenic Noncoding RNAs

  2013cited by this paper
• Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial.

  2013cited by this paper
• Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome

  2012cited by this paper
• Landscape of transcription in human cells

  2012cited by this paper
• Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis

  2011cited by this paper
• Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.

  2008cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Polycystic ovary syndrome.

  1995cited by this paper
• Internal pilot studies for estimating sample size.

  1994cited by this paper
• 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected

  year unknowncited by this paper

• Biomarkers for effective prognosis of polycystic ovary syndrome: a full review.

  2026cites this paper
• Elevated expression of microRNA-155, microRNA-383, and microRNA-9 in Iranian patients with polycystic ovary syndrome

  2025cites this paper
• Long Noncoding RNA NONHSAT233728.1 Promotes ROS Accumulation and Granulosa Cell Apoptosis by Regulating the MAPK/ERK1/2 Signaling Pathway

  2025cites this paper
• Integrated Transcriptome Analysis of lncRNA, miRNA, and mRNA Reveals key Regulatory Modules for Polycystic Ovary Syndrome

  2024cites this paper
• Whispers of the polycystic ovary syndrome theater: Directing role of long noncoding RNAs

  2024cites this paper
• MALAT1 expression in granulosa cells in PCOS patients with different phenotypes

  2024cites this paper
• The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review

  2024influential citation
• Effect of lncRNA MALAT1 on the Granulosa Cell Proliferation and Pregnancy Outcome in Patients With PCOS

  2022cites this paper
• microRNAs and long non‐coding RNAs as biomarkers for polycystic ovary syndrome

  2022cites this paper
• Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer.

  2021cites this paper
• Down-regulation of MALAT1 aggravates polycystic ovary syndrome by regulating MiR-302d-3p-mediated leukemia inhibitory factor activity.

  2021cites this paper
• Long non-coding RNAs: novel players in the pathogenesis of polycystic ovary syndrome

  2021cites this paper
• Impact of exposures to persistent endocrine disrupting compounds on the sperm methylome in regions associated with neurodevelopmental disorders

  2021cites this paper
• Long non-coding RNA expression in non-obese women with polycystic ovary syndrome and weight-matched controls.

  2020cites this paper
• Long non-coding RNA lnc-CCNL1-3:1 promotes granulosa cell apoptosis and suppresses glucose uptake in women with polycystic ovary syndrome

  2020cites this paper
• lnc-MAP3K13-7:1 Inhibits Ovarian GC Proliferation in PCOS via DNMT1 Downregulation-Mediated CDKN1A Promoter Hypomethylation

  2020cites this paper
• Downregulation of Lnc-OC1 attenuates the pathogenesis of polycystic ovary syndrome.

  2020cites this paper
• Weighed Gene Coexpression Network Analysis Screens the Potential Long Noncoding RNAs and Genes Associated with Progression of Coronary Artery Disease

  2020cites this paper
• microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index

  2020cites this paper
• Expression of microRNA in follicular fluid in women with and without PCOS

  2019cites this paper